Central News Agency (CNA, reporter Shen Pei-yao, Taipei, June 30) Rotavirus is one of the main causes of gastroenteritis in children under 5, accounting for 50% of cases. Director-General of the Centers for Disease Control (CDC), Lo Yi-chun, brought good news today: starting next year, the rotavirus vaccine will be included in the publicly funded program. Depending on the vaccine type, parents can save up to NT$6,000. An estimated 120,000 infants will benefit in the first year. Infants infected with rotavirus may require hospitalization due to severe diarrhea. Lo Yi-chun, Director-General of the Ministry of Health and Welfare's CDC, explained at a regular epidemic briefing today that two brands of rotavirus vaccines are currently approved for use in Taiwan. These are a 2-dose and a 3-dose regimen, costing between NT$5,500 and NT$6,000. Lo Yi-chun stated that both vaccine brands can prevent severe rotavirus gastroenteritis by over 90%, significantly reducing the chance of hospitalization due to rotavirus infection. It is estimated that this can reduce the number of infant hospitalizations by 60,000 annually, and the incidence of adverse reactions is similar to that of the placebo group. Currently, 16 cities and counties already provide rotavirus vaccination for infants within their jurisdiction through self-purchase or subsidies. Lo Yi-chun said that to ensure a seamless transition, the CDC will procure the two vaccine brands using a 6:4 ratio. If infants need to be vaccinated earlier due to reasons such as traveling abroad, there must be at least a 4-week interval between doses. Additionally, considering some infants who live abroad with their parents long-term may not be able to return to Taiwan for vaccination, it is reminded that vaccination must not be later than 8 months of age. Infants born after June of this year are eligible, and an estimated 120,000 infants are expected to benefit in the first year. The CDC's plan to include the rotavirus vaccine in the inf